Current Impactful Studies: Difference between revisions
Richardpruen (talk | contribs) |
Richardpruen (talk | contribs) |
||
| Line 40: | Line 40: | ||
==[https://pubmed.ncbi.nlm.nih.gov/33269148/ Does Nicotine Prevent Cytokine Storms in COVID-19?]== | ==[https://pubmed.ncbi.nlm.nih.gov/33269148/ Does Nicotine Prevent Cytokine Storms in COVID-19?]== | ||
*We discuss how his excessive use of nicotine replacement therapy may have contributed to his emerging unscathed from COVID-19. Nicotine, an α7-nACh receptor agonist, may boost the cholinergic anti-inflammatory pathway and hinder the uncontrolled overproduction of pro-inflammatory cytokines triggered by the SARS-CoV-2 virus, which is understood to be the main pathway to poor outcomes and death in severe COVID-19. | |||
==[https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00406-y#Sec8 An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland] accompanying helpful blog here [https://filtermag.org/vaping-homelessness-ireland/ My Study of Providing Vapes to Unhoused Smokers in Ireland]== | ==[https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00406-y#Sec8 An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland] accompanying helpful blog here [https://filtermag.org/vaping-homelessness-ireland/ My Study of Providing Vapes to Unhoused Smokers in Ireland]== | ||